Neuroleptic malignant syndrome: hyperthermia, lead-pipe rigidity, altered consciousness, autonomic instability - stop drug, emergency.
Before you read
Test yourself first: 3 questions
Question 1 of 3
A client receiving haloperidol develops a sudden, painful spasm with the neck twisting to one side and the eyes deviating upward. Which intervention should the nurse anticipate?
Answer: A. This describes acute dystonia (torticollis and oculogyric crisis), an early extrapyramidal reaction. The treatment is an anticholinergic such as IM/IV benztropine or diphenhydramine, which rapidly relieves the spasm. It is uncomfortable but treatable; prompt administration is the expected intervention.
Question 2 of 3
A client receives haloperidol for acute agitation and develops sudden muscle stiffness, oculogyric crisis, and torticollis. Which intervention does the nurse anticipate?
Answer: A. These signs indicate an acute dystonic reaction, an extrapyramidal side effect of antipsychotics. The treatment is an anticholinergic or antihistamine such as benztropine or diphenhydramine, often given IM for rapid relief.
Question 3 of 3
A provider orders an IM injection of a medication for acute agitation that does not respond to verbal de-escalation. Which combination is a commonly used agent for chemical de-escalation?
Answer: A. Haloperidol combined with lorazepam (often with diphenhydramine to prevent dystonia) is a recognized regimen for acute agitation. The benzodiazepine sedates and the antipsychotic targets psychosis-driven agitation.
Keep the streak going with more questions like these, each with a full rationale.
What is haloperidol?
Because it strongly blocks dopamine, it causes prominent extrapyramidal symptoms (EPS) and carries the risk of neuroleptic malignant syndrome (NMS) and tardive dyskinesia. A long-acting decanoate IM form supports adherence. Memory aid: high-potency = high EPS.
Key points to remember
- Causes extrapyramidal symptoms: acute dystonia, akathisia, pseudoparkinsonism, and (long-term) tardive dyskinesia.
- Neuroleptic malignant syndrome (NMS) is a life-threatening reaction: high fever, muscle rigidity, altered mental status, autonomic instability.
- Can prolong the QT interval; monitor ECG, especially with IV use.
- Anticholinergic agents (benztropine, diphenhydramine) treat acute dystonic reactions and EPS.
- Tardive dyskinesia (involuntary facial/tongue movements) may be irreversible - assess with AIMS.
- Decanoate long-acting injection improves adherence; antipsychotic effect on positive symptoms develops over days to weeks.
Nursing priorities
- Monitor for and recognize EPS early; have anticholinergic rescue medication available for acute dystonia.
- Assess for NMS (fever, rigidity, elevated CK) and stop the drug if suspected.
- Perform AIMS assessment for tardive dyskinesia at regular intervals.
- Monitor ECG/QT interval and vital signs.
- Promote adherence and consider long-acting injectable for nonadherent patients.
Labs & values
Patient teaching
- Report muscle stiffness, high fever, and confusion immediately - this can be a medical emergency.
- Report any uncontrollable movements of the face, tongue, or limbs.
- Rise slowly to avoid dizziness and use sun protection due to photosensitivity.
- Do not stop the medication abruptly; keep follow-up appointments for movement assessments.
Red flags: report now
- Neuroleptic malignant syndrome: hyperthermia, lead-pipe rigidity, altered consciousness, autonomic instability - stop drug, emergency.
- Acute dystonia (oculogyric crisis, laryngospasm) - treat immediately with anticholinergic.
- Tardive dyskinesia (involuntary tongue/face movements) - report; may be irreversible.
- Prolonged QT or dysrhythmia.
References
Clinical references for this topic
